Skip to main content

Antiemetic Use During Pregnancy

Basic Details
Date Posted
Status
Complete
Medical Product
doxylamine
granisetron
metoclopramide HCL
netupitant/palonosetron HCl
ondansetron
palonosetron
prochlorperazine
promethazine HCl
succinate/pyridoxine HCl
Health Outcome(s)
exposure in pregnancy
Description

This report contains the prevalence of antiemetic use among women of reproductive age who delivered a liveborn infant in the Mini-Sentinel Distributed Database (MSDD). Results for antiemetic use are also presented for a matched comparator cohort with no live-birth deliveries during the request period.

Data from January 1, 2001 to December 31, 2014 from 15 Data Partners contributing to the MSDD were included in this report. This request was distributed to Data Partners on November 10, 2015.

Deliverables (1)
Mini-Sentinel Modular Program Report: Antiemetic Use During Pregnancy
Additional Details
FDA Center
CDER
Time Period
January 1, 2001 to December 31, 2014
Analysis Type
Custom Code
Population / Cohort
Females 54 years of age and younger
Data Sources
Mini-Sentinel Distributed Database (MSDD)
Related Links
Antiemetic Use Among Pregnant Women in the United States: The Escalating Use of Ondansetron
2016 ICPE Presentation: Ondasetron Use Among Pregnancies Identified in the Sentinel Distributed Database